Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
By B. Wilkoff, J. Cook, A. Epstein, Leon Greene, A. Hallstrom, H. Hsia, S. Kutalek, Arjun D Sharma, Brian Blatt, B. Karas and 89 more. Journal of the American Medical Association (JAMA), 2002
2,137 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/bb3c308163481cd79e5329de27e9d66d6e0c0b50
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- G. Fonarow
- T. Horwich
- Bernard R. Chaitman
- Jeroen J. Bax
- J. Cleland
- Helmut Baumgartner
- Rick A. Nishimura
- J. Halperin
In Surgery
Citations in the corpus
- ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. (2008, background): “Given the broader indication for and marked ncrease in implantation of ICDs for primary prevention hat is being driven by the results of the SCD-HeFT and ADIT II trials (332,333), understanding the frequency nd causes of inappropriate shocks and devising manage- ent strategies to mitigate both inapp”
- Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. (2005, neutral): “Thiazide at enrollment 52 (6) 60 (7) 63 (8)”
- 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013, background): “3 Un-necessary right ventricular (RV) pacing should be systematically avoided in patients with SB, since it may cause AF and deterioration of HF. 16,17 However, programming an excessively long AV interval to avoid RV pacing in patients with prolonged AV conduction may be disadvantageous from a haemo”
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “HF symptoms, increase hospitalization for HF, and increase mortality.(155,156) Use of CRT in patients with a conduction delay”
- ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006, background): “Avoidance of overly aggressive rate acceleration in rate-modulated modes and, in some recent pacemaker models, the use of an automatic pacing mode selecting algorithms that strongly favor atrial over ventricular pacing (271).”